Andrew Mok
Stock Analyst at Barclays
(2.49)
# 1,389
Out of 4,667 analysts
132
Total ratings
48.19%
Success rate
-0.77%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Underweight | $5 → $2 | $1.67 | +19.76% | 2 | Nov 11, 2024 | |
| THC Tenet Healthcare | Maintains: Overweight | $171 → $190 | $151.84 | +25.13% | 10 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Overweight | $396 → $392 | $333.00 | +17.72% | 8 | Nov 8, 2024 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $19 → $21 | $20.79 | +1.01% | 6 | Nov 8, 2024 | |
| CVS CVS Health | Maintains: Overweight | $75 → $71 | $56.83 | +24.93% | 6 | Nov 7, 2024 | |
| CI The Cigna Group | Maintains: Overweight | $405 → $420 | $323.39 | +29.87% | 3 | Nov 5, 2024 | |
| HUM Humana | Maintains: Equal-Weight | $250 → $253 | $293.97 | -13.94% | 5 | Oct 31, 2024 | |
| DVA DaVita | Maintains: Equal-Weight | $150 → $164 | $161.40 | +1.61% | 9 | Oct 31, 2024 | |
| ALHC Alignment Healthcare | Maintains: Underweight | $7 → $8 | $11.95 | -33.05% | 3 | Oct 30, 2024 | |
| EHC Encompass Health | Maintains: Overweight | $109 → $116 | $98.93 | +17.25% | 13 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $91 | $59.10 | +53.98% | 5 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $256 → $271 | $197.52 | +37.20% | 20 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $372 | $294.64 | +26.26% | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $5 | $3.83 | +30.55% | 4 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $604 → $603 | $600.50 | +0.42% | 4 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $622 → $501 | $397.48 | +26.04% | 5 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $76 | $39.10 | +94.37% | 10 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $57 → $79 | $82.16 | -3.85% | 4 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $120.99 | -31.40% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $35 | $22.51 | +55.49% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $180 | $0.74 | +24,224.32% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $7.46 | +60.86% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $90.00 | +5.56% | 7 | Aug 2, 2022 |
agilon health
Nov 11, 2024
Maintains: Underweight
Price Target: $5 → $2
Current: $1.67
Upside: +19.76%
Tenet Healthcare
Nov 8, 2024
Maintains: Overweight
Price Target: $171 → $190
Current: $151.84
Upside: +25.13%
HCA Healthcare
Nov 8, 2024
Maintains: Overweight
Price Target: $396 → $392
Current: $333.00
Upside: +17.72%
Privia Health Group
Nov 8, 2024
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $20.79
Upside: +1.01%
CVS Health
Nov 7, 2024
Maintains: Overweight
Price Target: $75 → $71
Current: $56.83
Upside: +24.93%
The Cigna Group
Nov 5, 2024
Maintains: Overweight
Price Target: $405 → $420
Current: $323.39
Upside: +29.87%
Humana
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $250 → $253
Current: $293.97
Upside: -13.94%
DaVita
Oct 31, 2024
Maintains: Equal-Weight
Price Target: $150 → $164
Current: $161.40
Upside: +1.61%
Alignment Healthcare
Oct 30, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.95
Upside: -33.05%
Encompass Health
Oct 29, 2024
Maintains: Overweight
Price Target: $109 → $116
Current: $98.93
Upside: +17.25%
Oct 29, 2024
Maintains: Overweight
Price Target: $97 → $91
Current: $59.10
Upside: +53.98%
Oct 25, 2024
Maintains: Overweight
Price Target: $256 → $271
Current: $197.52
Upside: +37.20%
Oct 25, 2024
Maintains: Equal-Weight
Price Target: $359 → $372
Current: $294.64
Upside: +26.26%
Oct 24, 2024
Maintains: Equal-Weight
Price Target: $3 → $5
Current: $3.83
Upside: +30.55%
Oct 22, 2024
Maintains: Overweight
Price Target: $604 → $603
Current: $600.50
Upside: +0.42%
Oct 22, 2024
Maintains: Overweight
Price Target: $622 → $501
Current: $397.48
Upside: +26.04%
Sep 30, 2024
Maintains: Overweight
Price Target: $83 → $76
Current: $39.10
Upside: +94.37%
Sep 6, 2024
Upgrades: Overweight
Price Target: $57 → $79
Current: $82.16
Upside: -3.85%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $120.99
Upside: -31.40%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $35
Current: $22.51
Upside: +55.49%
Jan 6, 2023
Maintains: Buy
Price Target: $300 → $180
Current: $0.74
Upside: +24,224.32%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $7.46
Upside: +60.86%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $90.00
Upside: +5.56%